Current Edition

Alex Gorsky

Amid consumer spinoff and CEO transition, Johnson & Johnson names new leadership team

Less than a month after revealing a plan to spin its consumer health business off as a new publicly traded company, Johnson & Johnson has …

Continue Reading →

Novartis may have a buyer for $21B generics unit Sandoz

Amid the industrywide push by Big Pharmas to spin off their generics and consumer businesses, Novartis may be on the verge of separating itself from …

Continue Reading →